PPARγ Agonist Suppresses TLR4 Expression and TNF-α Production in LPS Stimulated Monocyte Leukemia Cells

Cell Biochemistry and Biophysics

Volumn 60, Issue 3, 2011, Pages 167-172

  Wang, Chun Zhi ^a   Zhang, Yong ^a   Li, Xu Dong ^a   Hu, Yuan ^a   Fang, Zhi Gang ^a   Lin, Dong Jun ^a   Xiao, Ruo Zhi ^a   Huang, Ren Wei ^a   Huang, He Qing ^b   Liu, Pei Qing ^b   Liu, Jia Jun ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Leukemia; PPAR ; TLR; TNF

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CELL STRAIN U937; CELL SURVIVAL; DRUG POTENTIATION; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; LIPOPOLYSACCHARIDES; NF-KAPPA B; PPAR GAMMA; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 79958297465     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-010-9136-6     Document Type: Article

References (28)

1. Wu, S., Rhee, K. J., Albesiano, E., et al. (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nature Medicine, 15, 1016-1102.
2. Waldner, M. J., & Neurath, M. F. (2009). Colitis-associated cancer: The role of T cells in tumor development. Seminars in Immunopathology, 2009(31), 249-256.
3. Karin, M., et al. (2006). Nuclear factor-kappa B in cancer development and progression. Nature, 441, 431-436.
4. Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008). Cancer-related inflammation. Nature, 454, 436-444.
5. Grivennikov, S. I., Greten, F. R., & Karin, M. (2010). Immunity, inflammation, and cancer. Cell, 140(6), 883-899.
6. De Visser, K. E., Eichten, A., & Coussens, L. M. (2006). Paradoxical roles of the immune system during cancer development. Nature Reviews Cancer, 2006(6), 24-37.
7. Lin, W. W., & Karin, M. (2007). A cytokine-mediated link between innate immunity, inflammation and cancer. Journal of Clinical Investigation, 2007(117), 1175-1183.
8. Harmey, J. H., Bucana, C. D., Lu, W., Byrne, A. M., McDonnell, S., Lynch, C., et al. (2002). Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. International Journal of Cancer, 2002(101), 415-422.
9. Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860-867.
10. Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002). Cancer immunoediting: From immunosurveillance to tumor escape. Nature Immunology, 2002(3), 991-998.
11. Baldwin, A. S., Jr. (2001). Series introduction: The transcription factor NF-κB and human disease. Journal of Clinical Investigation, 2001(107), 3-6.
12. Karin, M., & Lin, A. (2002). NF-κB at the crossroads of life and death. Nature Immunology, 2002(3), 221-227.
13. Zoete, V., Grosdidier, A., & Michielin, O. (2007). Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators. Biochimica et Biophysica Acta, 1771(8), 915-925.
14. Kliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., et al. (1994). Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proceedings of the National Academy of Sciences United States of America, 91, 7355.
15. Issemann, I., & Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 1990(3), 645-650.
16. Pascual, G., Sullivan, A. L., Ogawa, S., Gamliel, A., Perissi, V., Rosenfeld, M. G., et al. (2007). Anti-inflammatory and antidiabetic roles of PPAR gamma. Novartis Foundation Symposium, 286, 183-196. (discussion 196-203).
17. Kurebayashi, S., et al. (2005). A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-α-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells. Atherosclerosis, 182, 71-77.
18. Strauss, D. S., & Glass, C. K. (2007). Anti-inflammatory actions of PPAR ligands: New insights on cellular and molecular mechanisms. Trends in Immunology, 28(12), 551-558.
19. Medzhitov, R., Preston Hurlburt, P., & Janeway, C. A., Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388(6640), 394-397.
20. Huang, Q., Liu, D., Majewski, P., et al. (2001). The plasticity of dendritic cell responses to pathogens and their components. Science, 294(5543), 870-875.
21. Muzio, M., Bosisio, D., Polentarutti, N., et al. (2000). Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cell. Journal of Immunology, 164(11), 5998-6004.
22. Luo, J.-L., Maeda, S., Hsu, L.-C., Yagita, H., & Karin, M. (2004). Inhibition of NF-[kappa]B in cancer cells converts inflammation-induced tumor growth mediated by TNF[alpha] to TRAIL-mediated tumor regression. Cancer Cell, 6(3), 297-305.
23. Kiechl, S., Lorenz, E., Reindl, M., et al. (2002). Toll-like receptor 4 polymorphisms and pathogenesis. New England Journal of Medicine, 347(3), l85-l192.
24. Luo, J.-L., Kamata, H., & Karin, M. (2005). IKK/NF-κB signaling: Balancing life, death-a new approach to cancer therapy. Journal of Clinical Investigation, 115(10), 2625-2632.
25. Rossi, A., et al. (2000). Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature, 403, 103-108.
26. Straus, D. S., et al. (2000). 15-deoxy-Δ12, 14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway. Proceedings of the National Academy of Sciences of the United States of America, 97, 4844-4849.
27. Reaves, T. A., Chin, A. C., et al. (2005). Neutrophil transepithelial migration: Role of toll like receptors in mucosal inflammation. Memórias do Instituto Oswaldo Cruz, 100(Supp l), 191-198.
28. Eun, C. S., Han, D. S., et al. (2006). Attenuation of colonic inflammation by PPARγ in intestinal epithelial cells: Effect on Toll-like receptor pathway. Digestive Diseases and Sciences, 51(4), 693-697.